Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT00506467Completed

Vibration Response Imaging (VRI) in Lung Cancer Patients

Role: collaborator

NCT01206621Unknown

Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED

Role: lead

NCT00966511Unknown

Vibration Response Imaging (VRI) in Patients Who Are Potential Candidates for Surgical Resection

Role: lead

NCT01229020Completed

Distribution of Regional Lung Function by Vibration Response Imaging

Role: lead

NCT00992966Suspended

Vibration Response Imaging (VRI) in Children With Acute Respiratory Symptoms

Role: lead

NCT00523094Suspended

Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure

Role: lead

NCT00672893Completed

Vibration Response Imaging (VRI) in Patients That Are Undergoing Pulmonary Interventional Procedure

Role: lead

NCT00542282Completed

Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma

Role: lead

NCT00495430Unknown

Vibration Response Imaging in Healthy Subjects

Role: lead

NCT00473291Completed

Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion

Role: lead

NCT00744822Completed

Vibration Response Imaging (VRI) in Lung Transplant Recipients

Role: collaborator

All 11 trials loaded